Your browser doesn't support javascript.
loading
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.
Laroni, Alice; Brogi, Davide; Brescia Morra, Vincenzo; Guidi, Leonello; Pozzilli, Carlo; Comi, Giancarlo; Lugaresi, Alessandra; Turrini, Renato; Raimondi, Debora; Uccelli, Antonio; Mancardi, Giovanni Luigi.
Afiliación
  • Laroni A; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Largo Daneo 3, 16132, Genoa, Italy.
  • Brogi D; IRCCS San Martino-IST, Genova, Italy.
  • Brescia Morra V; Center of Excellence for Biomedical Research, Genova, Italy.
  • Guidi L; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Largo Daneo 3, 16132, Genoa, Italy.
  • Pozzilli C; Department of Neurological Sciences, University Federico II, Naples, Italy.
  • Comi G; Neurology Unit, S. Giuseppe Hospital, Empoli, Italy.
  • Lugaresi A; Department of Neurology, University La Sapienza, Rome, Italy.
  • Turrini R; Department of Neurology, Scientific Institute, INSPE, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Milan, Italy.
  • Raimondi D; Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio, Chieti, Italy.
  • Uccelli A; Novartis Farma, Origgio, Varese, Italy.
  • Mancardi GL; Novartis Farma, Origgio, Varese, Italy.
Neurol Sci ; 38(1): 53-59, 2017 Jan.
Article en En | MEDLINE | ID: mdl-27757552

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Clorhidrato de Fingolimod / Inmunosupresores Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Clorhidrato de Fingolimod / Inmunosupresores Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Italia